Statistical Thinking for Non-Statisticians in Drug Regulation (inbunden, eng)
Statistical Thinking for Non-Statisticians in Drug Regulation (inbunden, eng)
Gästpris:
Ditt medlemspris:
707 kr
817 kr
Kampanjpris! (-6%)
Kampanjpris! (-19%)
- Inköpspriser för medlemmar (Logga in)
- Frakt från 0 kr
- 14 dagars öppet köp
Frågor? Starta chatt
STATISTICAL THINKING FOR NON-STATISTICIANS IN DRUG REGULATION Statistical methods in the pharmaceutical industry are accepted as a key element in the design and analysis of clinical studies. Increasingly, the medical and scientific community are aligning with the regulatory authorities and recognizing that correct statistical methodology is essential as the basis for valid conclusions.
In order for those correct and robust methods to be successfully employed there needs to be effective communication across disciplines at all stages of the planning, conducting, analyzing and reporting of clinical studies associated with the development and evaluation of new drugs and devices.
Statistical Thinking for Non-Statisticians in Drug Regulation provides a comprehensive in-depth guide to statistical methodology for pharmaceutical industry professionals, including physicians, investigators, medical science liaisons, clinical research scientists, medical writers, regulatory personnel, statistical programmers, senior data managers and those working in pharmacovigilance.
The author’s years of experience and up-to-date familiarity with pharmaceutical regulations and statistical practice within the wider clinical community make this an essential guide for the those working in and with the industry. The third edition of Statistical Thinking for Non-Statisticians in Drug Regulation includes: A detailed new chapter on Estimands in line with the 2019 Addendum to ICH E9Major new sections on topics including Combining Hierarchical Testing and Alpha Adjustment, Biosimilars, Restricted Mean Survival Time, Composite Endpoints and Cumulative Incidence Functions, Adjusting for Cross-Over in Oncology, Inverse Propensity Score Weighting, and Network Meta-AnalysisUpdated coverage of many existing topics to reflect new and revised guidance from regulatory authorities and author experience Statistical Thinking for Non-Statisticians in Drug Regulation is a valuable guide for pharmaceutical and medical device industry professionals, as well as statisticians joining the pharmaceutical industry and students and teachers of drug development.
In order for those correct and robust methods to be successfully employed there needs to be effective communication across disciplines at all stages of the planning, conducting, analyzing and reporting of clinical studies associated with the development and evaluation of new drugs and devices.
Statistical Thinking for Non-Statisticians in Drug Regulation provides a comprehensive in-depth guide to statistical methodology for pharmaceutical industry professionals, including physicians, investigators, medical science liaisons, clinical research scientists, medical writers, regulatory personnel, statistical programmers, senior data managers and those working in pharmacovigilance.
The author’s years of experience and up-to-date familiarity with pharmaceutical regulations and statistical practice within the wider clinical community make this an essential guide for the those working in and with the industry. The third edition of Statistical Thinking for Non-Statisticians in Drug Regulation includes: A detailed new chapter on Estimands in line with the 2019 Addendum to ICH E9Major new sections on topics including Combining Hierarchical Testing and Alpha Adjustment, Biosimilars, Restricted Mean Survival Time, Composite Endpoints and Cumulative Incidence Functions, Adjusting for Cross-Over in Oncology, Inverse Propensity Score Weighting, and Network Meta-AnalysisUpdated coverage of many existing topics to reflect new and revised guidance from regulatory authorities and author experience Statistical Thinking for Non-Statisticians in Drug Regulation is a valuable guide for pharmaceutical and medical device industry professionals, as well as statisticians joining the pharmaceutical industry and students and teachers of drug development.
| Format | Inbunden |
| Omfång | 432 sidor |
| Språk | Engelska |
| Förlag | John Wiley and Sons Ltd |
| Utgivningsdatum | 2022-12-29 |
| ISBN | 9781119867388 |
Artikelnummer
3222258
EAN
9781119867388
Leverans:
Denna produkt skickas från oss inom 6 - 7 vardagar. I kassan väljer du om du vill få leverans med Budbee, Airmee, Best Transport, Early Bird, Postnord eller DB Schenker. Vissa speditörer har vikt- eller storleksbegränsningar och kan av den anledningen saknas som alternativ i kassan om du handlar många eller väldigt stora produkter.Fri retur:
För medlemmar gäller fri retur och 14 dagars full returrätt från den dagen du tar emot din leverans. För övriga kostar retur från 49 kr.Undantag för retur- och ångerrätt:
Dessa är exempel på varor som inte omfattas av retur- eller ångerrätt. Observera att det kan finnas andra undantag som inte listas här.- Använda, skadade och/eller inkompletta produkter
- Dagligvaror (livsmedel, läkemedel, nikotinprodukter)
- Hygienartiklar & kroppsnära produkter (rakapparater, in ear-hörlurar, aktivitetsklockor)
- Intimprodukter (menskoppar, kondomer och glidmedel)
- Kosmetikprodukter (inkl. hår- och hudvårdsprodukter, parfymer, etc.)
- Underkläder (inkl. badkläder, underställ och strumpor)
- Ljud- & bildupptagningar, spel/program (om förseglingen brutits eller licensnyckeln erhållits.)
- Teknikprodukter om försegling brutits eller programvara har installerats (mobiltelefoner, surfplattor, laptops, etc.)
- Gratisprodukter
Om du är osäker på om en produkt omfattas av ångerrätt kan du alltid kontakta vår kundtjänst på info@buyersclub.se, så hjälper vi dig gärna!
Leveranser:
